That's 1 year longer than me so I (partially) feel your pain.
The strategy employed last year feels like the right one, I would never have bought in if they hadn't purchased Murray Meds. What they were doing before (health food) is a hard slog where the difference between a good month and a bad month could all rest on a single instagram post by an influencer. No thanks.
They still have another 9 tunnels to build and the ODC only approves expansions in cultivation if you can prove that all of the additional product has a customer waiting for it. In other words, demand still outstrips supply for ECS' products and that's a problem I can live with.
